Advertisement
Screener

SCHOLAR ROCK HOLDING CORPORATION (SRRK) Net Margin

Scholar Rock Holding Corp Net Margin

Net margin is the percentage of revenue a company keeps as profit after every expense and tax. It is net income divided by revenue, and the table shows both amounts beside the percentage. A higher net margin means more of each sales dollar reaches the bottom line. One-time gains, write-downs and tax items pass through net income, so a single period's net margin can move for reasons unrelated to the underlying business. Quarterly and annual points each use the amounts filed for that same period, so a single quarter can swing with the seasons.

  • Scholar Rock Holding Corp net margin for the quarter ending 2022-03-31 was -23.95%, a change of 563.79% year-over-year.
  • Scholar Rock Holding Corp net margin for the quarter ending 2021-12-31 was -886.98%, a change of -113.67% year-over-year.
  • Scholar Rock Holding Corp net margin for the quarter ending 2021-09-30 was -686.44%, a change of 89.36% year-over-year.
  • Scholar Rock Holding Corp net margin for the quarter ending 2021-06-30 was -668.27%, a change of -173.89% year-over-year.
  • Scholar Rock Holding Corp net margin for fiscal 2022 was -405.21%, a change of 295.25% from fiscal 2021.
  • Scholar Rock Holding Corp net margin for fiscal 2021 was -700.46%, a change of -138.99% from fiscal 2020.
  • Scholar Rock Holding Corp net margin for fiscal 2020 was -561.47%, a change of -312.59% from fiscal 2019.
  • Scholar Rock Holding Corp net margin for fiscal 2019 was -248.88%.
Available history
2019-03-31 to 2022-12-31
Data captured

Historical Net Margin

DateNet MarginNet incomeRevenue
2022-03-31-23.95%-$7.95M$33.19M
2021-12-31-886.98%-$35.91M$4.05M
2021-09-30-686.44%-$37.51M$5.46M
2021-06-30-668.27%-$30.71M$4.6M
2021-03-31-587.74%-$27.67M$4.71M
2020-12-31-773.31%-$26.57M$3.44M
2020-09-30-775.80%-$23.56M$3.04M
2020-06-30-494.38%-$19.28M$3.9M
2020-03-31-339.36%-$17.07M$5.03M
2019-12-31-152.82%-$11.57M$7.57M
2019-09-30-338.23%-$16.15M$4.77M
2019-06-30-248.56%-$12.53M$5.04M
2019-03-31-346.27%-$10.76M$3.11M

Annual Net Margin

DateNet MarginNet incomeRevenue
2022-12-31-405.21%-$134.5M$33.19M
2021-12-31-700.46%-$131.8M$18.82M
2020-12-31-561.47%-$86.48M$15.4M
2019-12-31-248.88%-$51M$20.49M

Similar stocks

Stock NameCountryMarket CapPE Ratio
CG Oncology, Inc. (CGON)United States$6.095B-27.95
CRISPR Therapeutics AG (CRSP)$5.390B-11.68
IOVANCE BIOTHERAPEUTICS, INC. (IOVA)United States$4.897B-6.51
Immunovant, Inc. (IMVT)United States$7.028B-14.78
Adaptive Biotechnologies Corp (ADPT)United States$4.719B-53.43
Relay Therapeutics, Inc. (RLAY)United States$3.884B-14.30
Vaxcyte, Inc. (PCVX)United States$8.466B-7.91
Tarsus Pharmaceuticals, Inc. (TARS)United States$3.329B-58.60
Denali Therapeutics Inc. (DNLI)United States$3.274B-8.04
ImmunityBio, Inc. (IBRX)United States$9.157B-9.29